Dabigatran etexilate retards the initiation and progression of atherosclerotic lesions and inhibits the expression of oncostatin M in apolipoprotein E-deficient mice - Preusch, Michael; Ieronimakis, Nicholas; Wijelath, Errol S; Cabbage, Sara; Ricks, Jerry; Bea, Florian; Reyes, Morayma; van Ryn, Joanne; Rosenfeld, Michael E (Drug design, development and therapy, 2015)
Gesehen am 15.07.2020